The extracellular factors that determine a cell's responsiveness to neurotransmitters are of particular relevance for pharmacologically diverse cell types such as neurons and smooth muscle. We previously demonstrated that matrix-associated factors are capable of dramatically and specifically suppressing the responsiveness of smooth muscle to the neuropeptide, substance P. We now demonstrate that this influence of extracellular matrix on the pharmacological phenotype of smooth muscle cells can be blocked specifically by an Arg-Gly-Asp (RGD)-containing antagonist of integrins. Of a battery of integrin ligands tested, only thrombospondin mimicked the effect of the extracellular matrix on substance P responsiveness. This effect of thrombospondin was dose dependent, RGD sensitive, and blocked by an antibody directed against the RGD-containing region of thrombospondin. Because the mRNA for thrombospondin is present in the cells of the chicken amnion, this extracellular factor may normally suppress substance P responsiveness in amniotic smooth muscle. The results suggest a role for matrix-associated integrin ligands in the regulation of cellular responses to specific neurotransmitters and hormones and in the development and maintenance of tissue-specific pharmacological properties.The ability of the extracellular matrix (ECM) to influence the phenotype of a variety of cell types is well established (1). Important effects of ECM include simple changes in cell shape (e.g., adhesion and spreading in vitro), migration, proliferation, differentiative morphogenesis, and subcellular localization of neurotransmitter receptors. Certain effects of ECM appear to result from cellular interaction with abundant, generic components of the matrix [e.g., laminin (2-4)], whereas other effects are due to more specialized factors of limited distribution that are associated with the matrix [e.g., agrin (5)]. Many interactions of a cell with its immediate environment are mediated by ECM-specific receptors on the cell surface. A particularly well-characterized family of such receptors is the integrins, originally described as binding the Arg-Gly-Asp (RGD)-containing domains of their ligands (6); it is now clear that many integrins also bind ligands in an RGD-independent fashion (7). Other types of receptors are also involved in cell-matrix interaction, including proteoglycans located in the plasma membrane (5, 8). The ECM is in a unique position with regard to the regulation of cellular phenotype due to its molecular complexity, its ability to bind and concentrate otherwise soluble factors, and its direct proximity to cells. events, and when and where to place these receptors on the cell surface. Work from both neurons and muscle suggests that extracellular factors play important instructive roles in the process of receptor regulation. For example, nonneuronal cells from sensory ganglia powerfully suppress nicotinic receptor expression in dissociated sensory neurons (9), and extracellular factors, associated with ECM, direct the aggr...